Stereochemical effects of 11-OH-Δ8-THC-dimethylheptyl in mice and dogs

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1989-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0091-3057(89)90014-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereochemical requirements for cannabimimetic activity.

  1987cited by this paper
• Structure-activity relationships of the cannabinoids.

  1987cited by this paper
• Cellular effects of cannabinoids.

  1986cited by this paper
• High-affinity cannabinoid binding sites in brain membranes labeled with [3H]-5'-trimethylammonium delta 8-tetrahydrocannabinol.

  1985cited by this paper
• Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions.

  1983cited by this paper
• Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?

  1977cited by this paper
• Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs.

  1975cited by this paper
• Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivatives.

  1973cited by this paper
• The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice

  1972cited by this paper
• The effects of chronic administration of trans- 9 -tetrahydrocannabinol on behavior and the cardiovascular system of dogs.

  1972cited by this paper
• Structure-activity relationships in the tetrahydrocannabinol series. Modifications on the aromatic ring and it the side-chain.

  1972cited by this paper
• The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.

  1970cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (-) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives

  2025cites this paper
• An emerging trend in Novel Psychoactive Substances (NPSs): designer THC

  2024cites this paper
• Cannabinoids: revealing their complexity and role in central networks of fear and anxiety.

  2021cites this paper
• Molecular Mechanism and Cannabinoid Pharmacology.

  2020cites this paper
• Cannabinoid Geometry and Biological Activity

  2019cites this paper
• Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol.

  2019cites this paper
• The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution.

  2018cites this paper
• Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's disease and Less Well-Known Diseases.

  2018cites this paper
• Synthetic Cathinones and Cannabinoids are New Psychoactive Substances (Review)

  2017influential citation
• The central cannabinoid receptor type-2 (CB2) and chronic pain

  2017cites this paper
• Neurochemistry of Abuse Liability Assessment and Primary Behavioral Correlates

  2015cites this paper
• Cannabinoids: structures, effects, and classification

  2015cites this paper
• Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure

  2014cites this paper
• The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.

  2014cites this paper
• Expression of genes in the 111.35–116.16 million bp fragment of chromosome 13 in brain of mice with different predisposition to hereditary catalepsy

  2014cites this paper
• Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration.

  2014cites this paper
• Blocking the postpartum mouse dam's CB1 receptors impairs maternal behavior as well as offspring development and their adult social-emotional behavior.

  2012cites this paper
• Long-term use of HU210 adversely affects spermatogenesis in rats by modulating the endocannabinoid system.

  2012cites this paper
• Acute Cannabinoid Treatment 'in vivo' Causes an Astroglial CB1R-Dependent LTD At Excitatory CA3-CA1 Synapses Involving NMDARs and Protein Synthesis

  2012cites this paper
• Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC-MS/MS.

  2012cites this paper
• Chapitre 16 – Nouvelles drogues

  2012cites this paper
• Searching for novel ligands for the cannabinoid and related receptors.

  2011cites this paper
• Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.

  2010cites this paper
• Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids

  2009cites this paper
• UNIVERSIDADE DE SÃO PAULO INSTITUTO DE QUÍMICA DE SÃO CARLOS Estudo da modelagem molecular do receptor canabinoide CB1 e suas interações com o Δ 9 - THC

  2009cites this paper
• Cannabinoid system in neurodegeneration: new perspectives in Alzheimer's disease.

  2009cites this paper
• Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists

  2009cites this paper
• HU210-Induced Downregulation in Cannabinoid CB1 Receptor Binding Strongly Correlates with Body Weight Loss in the Adult Rat

  2009cites this paper
• Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210.

  2008cites this paper
• CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.

  2007cites this paper
• Discovery and Isolation of Anandamide and Other Endocannabinoids

  2007cites this paper
• Modulation of morphine and alcohol motor stimulant effects by cannabinoid receptors ligands.

  2007cites this paper
• Medicinal Chemistry Endeavors around the Phytocannabinoids

  2007cites this paper
• Behavioral methods in cannabinoid research.

  2006cites this paper
• Hu 210: a potent tool for investigations of the cannabinoid system.

  2006cites this paper
• Marijuana and Cannabinoid Research

  2005cites this paper
• Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats

  2005cites this paper
• Cannabinoid Chemistry: An Overview

  2005cites this paper
• Clinical Pharmacodynamics of Cannabinoids

  2004cites this paper
• Augmentation of the Development of Behavioral Tolerance to Cannabinoid Administration through Pavlovian Conditioning

  2004cites this paper
• Derivatives of Dexanabinol. I. Water-Soluble Salts of Glycinate Esters

  2004cites this paper
• Pharmacokinetics and Pharmacodynamics of Cannabinoids

  2003influential citation
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cites this paper
• Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models.

  2002cites this paper
• Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.

  2002cites this paper
• Assessment of structural commonality between tetrahydrocannabinol and anandamide.

  2002cites this paper
• Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.

  2001cites this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cites this paper
• Cannabinoid receptors and pain.

  2001cites this paper
• Pharmacology of the Intraocular Pressure (IOP) Lowering Effect of Systemic Dexanabinol (HU-211), A Non-Psychotropic Cannabinoid

  2000cites this paper
• THE CANNABINOID AGONIST HU 210 MODIFIES RAT BEHAVIOURAL RESPONSES TO NOVELTY AND STRESS.

  2000cites this paper
• Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour.

  2000cites this paper
• Dexanabinol (HU‐211): A nonpsychotropic cannabinoid with neuroprotective properties

  2000cites this paper
• Effects of the cannabinoid receptor agonist, HU 210, on ingestive behaviour and body weight of rats.

  2000cites this paper
• Marihuana and Intraocular Pressure

  1999cites this paper
• From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis.

  1999cites this paper
• Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

  1999cites this paper
• Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug.

  1999cites this paper
• Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.

  1999cites this paper
• Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

  1999cites this paper
• Marijuana and Medicine

  1999cites this paper
• Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task.

  1999cites this paper
• Discovery and characterization of endogenous cannabinoids.

  1999cites this paper
• Analgesic Properties of THC and Its Synthetic Derivatives

  1999cites this paper
• Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.

  1998cites this paper
• Cannabinoid transmission and pain perception.

  1998cites this paper
• Pharmacology of Cannabis

  1998cites this paper
• Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.

  1998cites this paper
• CLEW: The Generation of Pharmacophore Hypotheses Through Machine Learning

  1998cites this paper
• Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

  1997cites this paper
• Structure–activity relationships of cannabinoids: A joint CoMFA and pseudoreceptor modelling study

  1997cites this paper
• College on problems of drug dependence meeting, Puerto Rico (June 1996) marijuana use and dependence.

  1997cites this paper
• Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.

  1997influential citation
• Endogenous and Synthetic Cannabinoids: Recent Advances

  1996cites this paper
• Cannabinoid Inhibition of Adenylate Cyclase-mediated Signal Transduction and Interleukin 2 (IL-2) Expression in the Murine T-cell Line, EL4.IL-2*

  1996cites this paper
• Cannabis: pharmacology and toxicology in animals and humans.

  1996cites this paper
• Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

  1996cites this paper
• Cardiovascular effects of (−)-11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl in rats

  1996cites this paper
• Pharmacology of cannabinoid receptors.

  1995cites this paper
• Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens.

  1995cites this paper
• Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

  1995cites this paper
• Progress toward understanding the cannabinoid receptor and its second messenger systems.

  1994cites this paper
• Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid.

  1994cites this paper
• Search for endogenous ligands of the cannabinoid receptor.

  1994cites this paper
• Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.

  1994cites this paper
• CNS Cannabinoid Receptors

  1994cites this paper
• Blockade of 45Ca2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211.

  1993cites this paper
• The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain

  1993cites this paper
• The evidence for the existence of cannabinoid receptors.

  1993cites this paper
• Overview: Recent Advances in the Medicinal Chemistry of Cannabinoids

  1993cites this paper
• Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

  1992cites this paper
• Inhibition of adenylate cyclase by delta 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression.

  1992cites this paper
• The antinociceptive effects of intrathecally administered cannabinoids are influenced by lipophilicity

  1992cites this paper
• Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestine

  1992cites this paper
• Effect of synthetic enantiomeric cannabinoids on platelet aggregation.

  1992cites this paper
• Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

  1991cites this paper
• Suppression of neuropathic pain behavior in rats by a non‐psychotropic synthetic cannabinoid with NMDA receptor‐blocking properties

  1991cites this paper
• Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids.

  1991cites this paper
• A random walk through a cannabis field.

  1991cites this paper
• Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative

  1990cites this paper